Jane M. Liebschutz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.818Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100135

Top 25%

0.818DataRank

Top 25%12 citations

Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak +2 more

Papers

Driven by 24 papers — median percentile 75. Top paper: “Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design”.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100135

Top 25%

0.818DataRank

Top 25%12 citations

Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak +2 more

Hazardous alcohol use is associated with greater pain interference and prescription opioid misuse among persons living with HIV and chronic pain

BMC Public Health(2021)10.1186/s12889-021-10566-6

N/A

0.750DataRank · unranked

17 citations

Jane M. Liebschutz, Debbie M. Cheng, Jonathan Colasanti, Jessica S. Merlin, Wendy S. Armstrong +6 more

“I Refused to Get Addicted to Opioids”: Exploring Attitudes About Opioid Use Disorder in Patients With Advanced Cancer Pain and Their Support People

Journal of Pain(2023)10.1016/j.jpain.2023.01.015

N/A

0.360DataRank · unranked

10 citations

Megan Hamm, Rachel Wasilko, Flor de Abril Cameron, Shane Belin, Burel R. Goodin +6 more

Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people with HIV: The STOMP protocol

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107163

N/A

0.314DataRank · unranked

6 citations

Matthew J. Bair, Sarah Orris, Mallory O. Johnson, Jane M. Liebschutz, William Demonte +15 more

Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial

Substance Use &amp Addiction Journal(2024)10.1177/29767342241261562

N/A

0.241DataRank · unranked

4 citations

Karlyn A. Edwards, Erin L. Winstanley, Rachel L. Bachrach, Hailey W. Bulls, Janel Hanmer +7 more

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder

Addiction Science & Clinical Practice(2024)10.1186/s13722-024-00510-5

N/A

0.165DataRank · unranked

2 citations

Kelly S. Barth, Paulette Baukol, Eva A. Enns, Udi E. Ghitza, Jacklyn Harris +7 more

“I don’t tell anyone I have them:” Experiences with opioid stigma from the perspective of survivors living with chronic cancer-related pain and clinicians that care for them

Journal of Pain(2025)10.1016/j.jpain.2025.105411

N/A

0.104DataRank · unranked

1 citations

Megan Hamm, Julia Wasilewski, Rachel Wasilko, Donna Olejniczak, Geetha Subramaniam +3 more

Why is substance use missing from my patient's problem list? CTN research to advance screening, prevention, and treatment of substance use in primary care

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209780

N/A

0.104DataRank · unranked

1 citations

Katharine A. Bradley, Jane M. Liebschutz, Geetha Subramaniam, Jennifer McNeely

Optimizing evidence-based practice implementation: a case study on simulated patient protocols in long-term opioid therapy

Implementation Science Communications(2024)10.1186/s43058-024-00575-y

N/A

0.104DataRank · unranked

1 citations

Megan Hamm, Catherine Gowl, Reed Van Deusen, Jane M. Liebschutz, J. Deanna Wilson +2 more

Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder

Addiction(2024)10.1111/add.16473

N/A

0DataRank · unranked

11 citations

Sara Lodi, Heather Hsu, Benjamin J. Bovell-Ammon, Shapei Yan, Dana Bernson +7 more

Changes in Buprenorphine Prescribing After X-Waiver Exemptions: An Interrupted Time Series Analysis

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110167

N/A

0DataRank · unranked

0 citations

Katie J. Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak +2 more

Reply to “Embracing an ethical‐legal framework for balanced opioid prescribing: A reply to Bulls”

Cancer(2024)10.1002/cncr.35487

N/A

0DataRank · unranked

0 citations

Megan Hamm, Julia Wasilewski, Donna Olejniczak, Sarah Bell, Jane M. Liebschutz +1 more

Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone on Treatment Interruption: Comparing Findings from a Reanalysis of the X:Bot Rct and Harmonized Target Trial Emulation Using Population-Based Observational Data

SSRN Electronic Journal(2024)10.2139/ssrn.4933445

N/A

0DataRank · unranked

0 citations

Shapei Yan, Benjamin J. Bovell-Ammon, Paul J. Christine, Heather Hsu, Dana Bernson +7 more

Characterizing Barriers to Substance Use treatment: A Latent Class Analysis Using the NSDUH 2020-2021 Surveys

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112108

N/A

0DataRank · unranked

0 citations

Bryant Shuey, Lakeya McGill, Jessica S. Merlin, Jane M. Liebschutz, Karlyn A. Edwards

Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1025

N/A

0DataRank · unranked

25 citations

Judith I. Tsui, Debbie M. Cheng, Jane M. Liebschutz, Marlene C. Lira, Alexander Y. Walley +12 more

Identifying Barriers and Facilitators to Pain Management With Buprenorphine for Patients With Kidney Failure: A Thematic Analysis of Interviews With Key Partners

Kidney Medicine(2025)10.1016/j.xkme.2025.101130

N/A

0DataRank · unranked

0 citations

Megan Hamm, Flor de Abril Cameron, Kerri L. Cavanaugh, Nwamaka D. Eneanya, Hailey W. Bulls +6 more

Exemptions to state laws regulating opioid prescribing for patients with cancer‐related pain: A summary

Cancer(2021)10.1002/cncr.33639

N/A

0DataRank · unranked

34 citations

Lindsay F. Bell, Steven R. Orris, Burel R. Goodin, Jane M. Liebschutz, Antoinette J. Wozniak +3 more

Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs

International Journal of Drug Policy(2021)10.1016/j.drugpo.2021.103198

N/A

0DataRank · unranked

29 citations

Michael D. Stein, Bradley J. Anderson, Jane M. Liebschutz, Catherine Stewart, Kristina T. Phillips +2 more

Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?

Journal of General Internal Medicine(2021)10.1007/s11606-021-07095-8

N/A

0DataRank · unranked

8 citations

Ricardo Cruz, Sarah Kosakowski, Doug L. Gourlay, Daniel P. Alford, Ziming Xuan +6 more

Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids

AIDS and Behavior(2021)10.1007/s10461-021-03460-0

N/A

0DataRank · unranked

6 citations

Michael D. Stein, Bradley J. Anderson, Jane M. Liebschutz, Catherine Stewart, Kristina T. Phillips +2 more

Expert consensus‐based guidance on approaches to opioid management in individuals with advanced cancer‐related pain and nonmedical stimulant use

Cancer(2023)10.1002/cncr.34921

N/A

0DataRank · unranked

12 citations

Dmitry Khodyakov, Benjamin H. Han, Robert M. Arnold, Emily Dao, Jeni Morrison +8 more

Stakeholder-Driven Intervention Development for Dialysis Trials Using a Design Sprint Methodology

Kidney Medicine(2023)10.1016/j.xkme.2023.100729

N/A

0DataRank · unranked

4 citations

Kerri L. Cavanaugh, Megan Hamm, Caroline Wilkie, Donna Olejniczak, Nwamaka D. Eneanya +5 more

Anti-hypertensive Medication Use Among People with and without Substance Use Disorders

Journal of General Internal Medicine(2023)10.1007/s11606-023-08543-3

N/A

0DataRank · unranked

1 citations

Katie J. Suda, Alyssa Halbisen, Hefei Wen, J. Frank Wharam, Ann‐Marie Rosland +2 more

Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104381

N/A

0DataRank · unranked

36 citations

Katie J. Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak +2 more

Jane M. Liebschutz

Indexed papers

Top data-sharing exemplar

Papers